Navigation Links
Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
Date:4/6/2009

Nanyang Technological University (NTU) and Imperial College London have signed an agreement on 6 April 2009 that will enable these two leading universities to offer highly attractive joint Doctor of Philosophy (PhD) programmes in engineering and science.

The NTU-Imperial College Joint PhD degree programme will commence with PhD programmes in Bioengineering and Chemical and Biomolecular Engineering. It will subsequently be extended to PhD degrees for all engineering and science disciplines. Successful PhD candidates shall be jointly issued a PhD degree under the seal of Imperial College and the seal of NTU.

This collaboration is also a milestone for both NTU and Imperial College as this is the first time that they are offering a joint PhD programme with a partner university.

The programme is expected to be highly competitive as it offers participants the opportunity to be exposed to the research environments in two highly advanced universities in Singapore and UK. Synergistic combination of research resources, such as world-class talent and cutting-edge research facilities, is expected to draw the best students and faculties to the programme.

The Memorandum of Understanding (MOU) for the joint PhD programme was signed at NTU, by Sir Roy M. Anderson, Rector, Imperial College and Dr Su Guaning, NTU President.

"We are delighted to partner Imperial College London, a world renowned institution in education and research on this very exciting joint PhD programme. The collaboration will benefit our students and facilitate and strengthen the research collaboration between the two universities through joint PhD student education. We are confident that this joint programme, which will commence with programmes under NTU's School of Chemical and Biomedical Engineering (SCBE), will prove to be successful. We want to see it flourish to include all of NTU's engineering and science disciplines," says Dr Su.

Rector of Imper
'/>"/>

Contact: Hisham Hambari
mhisham@ntu.edu.sg
656-790-6447
Nanyang Technological University
Source:Eurekalert

Page: 1 2

Related biology news :

1. KAUST announces academic excellence alliance partnership with Imperial College London
2. American College of Medical Genetics responds to new FDA labeling decision for warfarin
3. Study finds a high rate of asthma in college athletes
4. Boston College profs study oxidative stress subcellular to discover its role in diseases
5. University of Minnesota releases first ever comprehensive report of the health of college students
6. 2 federal public health grants awarded to Weill Cornell Medical College
7. Software developed by Boston College lab delivers speed and accuracy to genome research
8. Veterinary college researcher studying brain tumors in people and animals
9. Veterinary college researchers explore function of biofilm in bovine respiratory disease
10. Where college students live can impact their weight, eating and exercise habits
11. Medical College researchers find dinosaur clues in fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... OXFORD, Conn. , May 20, 2015 ... "Company") announces that its wholly owned subsidiary, 3D-ID LLC, ... contractor under Team Battelle for the biometrics technology portion ... Unrestricted Suite Contract from the Department of the Army. ... facial recognition products developed for government, law enforcement and ...
(Date:5/19/2015)... -- Technology is rapidly advancing, outpacing enterprises, ability to secure ... and their management are soon to be rendered obsolete ... as those developed by the FIDO Alliance™. With the ... BYOD, COPE, IoT, and mobile payments, the interconnected online ... In response to the call for seamless, secure, ...
(Date:5/18/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... athletes looking to boost performance comes in the form of ... for its popularity is twofold says Scott Forbes, a doctoral ... for nitric oxide that is known to improve blood flow, ... to working muscles and assist with metabolic waste product removal. ...
... Bethesda, MD The Association for Molecular Pathology ... to exclusively license the subject matter of a cancer-related ... written remarks were submitted to NIH in response to ... entitled, "Prospective Grant of Exclusive License: The Development of ...
... of engineering principles to understand and treat medical conditions ... damage to the brain caused by a traumatic injury. ... presented in a special issue of Journal of ... Liebert, Inc. ( http://www.liebertpub.com ) The entire issue is ...
Cached Biology News:L-arginine: Supplement tested on fit, athletic men shows no advantage 2L-arginine: Supplement tested on fit, athletic men shows no advantage 3AMP opposes exclusive licensing of NIH proteomics patent 2Bioengineering yields new approaches for diagnosing and treating traumatic brain injury 2
(Date:6/1/2015)... (PRWEB) June 01, 2015 Sistemic ... have entered into a commercial collaboration agreement and ... will combine their technologies and work together towards ... regenerative technology. RoosterBio and Sistemic will collaborate on ... to build more precise and relevant characterization panels ...
(Date:6/1/2015)... , June 1, 2015  Berg, a biopharmaceutical company ... approach, presented clinical research from its trials using its ... and preclinical data on triple negative breast cancer, at ... Society of Clinical Oncology (ASCO), May 29 – June ... BPM 31510 is one of the first cancer ...
(Date:6/1/2015)... 29, 2015 Research and Markets( ... the "2015 Strategies in the US ... their offering. This new 373-page ... comprehensive analysis of the POC clinical chemistry ... requirements, technological trends, competitive landscape, and emerging ...
(Date:6/1/2015)... June 1, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced positive, ... clinical trial of AST-VAC1 in patients with intermediate ... is the Company,s autologous (using cells sourced from ... is the most common form of acute leukemia ...
Breaking Biology Technology:Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 2Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 3Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 4Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 2Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 3Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 4Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 5Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 6Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 7
... for Combining Efficiency and Renewables into an Energy ... recognized as an important component to America' energy ... discussion about including Energy Efficiency into what many ... Standards (RPS) . The whole idea being that ...
... saw around business computing that you should improve processes before ... the business side could just get its act together and ... And if your only objective is to automate what youre ... leaves a lot of technology value on the table and ...
... been awarded the maximum $250,000 grant from the ... program for its enzyme research. The grant program is ... high potential value. , ,Under the program, NSF matched ... outside investors. , ,The award will speed commercialization of ...
Cached Biology Technology:Energy efficiency is no longer the Rodney Dangerfield of energy 2Energy efficiency is no longer the Rodney Dangerfield of energy 3Innovate, Automate, or Improve? You Don't Have to Choose. 2Innovate, Automate, or Improve? You Don't Have to Choose. 3
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Mouse BLC/BCA 1 - 10kDa...
Preadipocyte factor-1 [Pref-1, DLK-1], C-terminal...
Biology Products: